Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).

作者: Rohit Ranade , Purushottam Kand , Sandip Basu

DOI: 10.1097/MNM.0000000000000350

关键词: Internal medicineGastroenterologyMedicineHistopathologyFluorodeoxyglucoseThyroid cancerCancerThyroid carcinomaThyroglobulinMetastasisProspective cohort studyPathology

摘要: AIMS The aim of the study was to investigate prognostic value fluorine-18 fluorodeoxyglucose (18F-FDG) PET negativity and thyroglobulin (Tg) suppressibility in differentiated thyroid carcinoma patients with elevated Tg a negative radioiodine scan. MATERIALS AND METHODS population selected from cancer registered at large tertiary care center for management consisted metastatic on follow-up, 131I whole-body scan 18F-FDG PET/computed tomography (CT) study. Patients were subjected thyroid-stimulating hormone-stimulated assessment basis scan, serum level PET/CT evaluation disease burden. same follow-up under hormone suppression while thyroxine sodium. Comparison also made between findings demonstrating suppressible Tg. RESULTS A total 40 (25 male 15 female) included All had but stimulated more than 5 ng/dl (range: 5.1-> 250 ng/ml), indicating presence disease. demonstrated variable classified extent (%Tg > 90% 21 patients; %Tg 65-90% 12 65%) is observed significant fraction these patients, which appears be independent status metastasis or histopathology. Also who show no still better prognosis indicated by disease-free interval as our Whether there exists any relation their long-term outcome requires further examined future prospective studies.

参考文章(14)
Bart de Keizer, Hans P. F. Koppeschaar, Pierre M. J. Zelissen, Cees J. M. Lips, Peter P. van Rijk, Aalt van Dijk, John M. H. de Klerk, Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 198- 202 ,(2001) , 10.1007/S002590000443
Hongming Zhuang, Rakesh Kumar, Susan Mandel, Abass Alavi, Investigation of thyroid, head, and neck cancers with PET Radiologic Clinics of North America. ,vol. 42, pp. 1101- 1111 ,(2004) , 10.1016/J.RCL.2004.07.006
Y Hosaka, M Tawata, A Kurihara, M Ohtaka, T Endo, T Onaya, The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology. ,vol. 131, pp. 159- 165 ,(1992) , 10.1210/ENDO.131.1.1319316
Bryan R. Haugen, Eugene C. Lin, Isotope imaging for metastatic thyroid cancer. Endocrinology and Metabolism Clinics of North America. ,vol. 30, pp. 469- 492 ,(2001) , 10.1016/S0889-8529(05)70195-X
SEBASTIANO FILETTI, GIUSEPPE DAMANTE, DANIELA FOTI, Thyrotropin Stimulates Glucose Transport in Cultured Rat Thyroid Cells Endocrinology. ,vol. 120, pp. 2576- 2581 ,(1987) , 10.1210/ENDO-120-6-2576
Weiping Wang, Steven M Larson, Melissa Fazzari, Satish K Tickoo, Katherine Kolbert, George Sgouros, Henry Yeung, Homer Macapinlac, Juan Rosai, Richard J Robbins, Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer Journal of Clinical Endocrinology & Metabolism. ,vol. 85, pp. 1107- 1113 ,(2000) , 10.1210/JC.85.3.1107
Martin Schlumberger, Maurice Tubiana, Olivier Arcangioli, Claude Parmentier, Jean Daniel Piekarski, Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. The Journal of Nuclear Medicine. ,vol. 29, pp. 1790- 1794 ,(1988)
Steven M. Larson, Richard Robbins, Positron emission tomography in thyroid cancer management Seminars in Roentgenology. ,vol. 37, pp. 169- 174 ,(2002) , 10.1016/S0037-198X(02)80035-9
T. Petrich, A. Börner, D. Otto, M. Hofmann, W. Knapp, Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 29, pp. 641- 647 ,(2002) , 10.1007/S00259-001-0745-6
Bushnell Dl, Wadas Ma, Boles Ma, Barnes We, Kaufman Ge, Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma. The Journal of Nuclear Medicine. ,vol. 33, pp. 2214- 2221 ,(1992)